Buscar
Mostrando ítems 1-10 de 447
ORAL OR INTRAVESICAL BACILLUS CALMETTE-GUERIN IMMUNOPROPHYLAXIS IN BLADDER-CARCINOMA
(Williams & WilkinsBaltimore, 1991)
HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population
(Wiley-Blackwell, 2008-08-01)
The morphologic appearance and clinical behavior of the human urinary bladder papillary transitional cell carcinoma (TCC) probably result from a complex interaction between carcinogenic insults and host resistance during ...
HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population
(Wiley-Blackwell, 2008-08-01)
The morphologic appearance and clinical behavior of the human urinary bladder papillary transitional cell carcinoma (TCC) probably result from a complex interaction between carcinogenic insults and host resistance during ...
Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma
(Faculdade de Medicina / USP, 2008)
OBJECTIVE: To describe the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinomas who are treated surgically and to analyze the occurrence of bladder tumors as well as the ...
Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine
(Soc Experimental Biology Medicine, 2010-07-01)
Currently, the combination of cisplatin and gemcitabine is considered a standard chemotherapeutic protocol for bladder cancer. However, the mechanism by which these drugs act on tumor cells is not completely understood. ...
Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine
(Soc Experimental Biology Medicine, 2010-07-01)
Currently, the combination of cisplatin and gemcitabine is considered a standard chemotherapeutic protocol for bladder cancer. However, the mechanism by which these drugs act on tumor cells is not completely understood. ...